NeuroSense Therapeutics Ltd. – NASDAQ:NRSNW
NeuroSense Therapeutics Ltd. stock price today
NeuroSense Therapeutics Ltd. stock price monthly change
NeuroSense Therapeutics Ltd. stock price quarterly change
NeuroSense Therapeutics Ltd. stock price yearly change
NeuroSense Therapeutics Ltd. key metrics
Market Cap | 45.45M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.86 |
Revenue | N/A |
EBITDA | -10.68M |
Income | -12.79M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNeuroSense Therapeutics Ltd. stock price history
NeuroSense Therapeutics Ltd. stock forecast
NeuroSense Therapeutics Ltd. financial statements
| Jun 2023 | 0 | -5.22M | |
|---|---|---|---|
| Sep 2023 | 0 | 784K | |
| Dec 2023 | 0 | -2.95M | |
| Mar 2024 | 0 | -5.40M |
| Jun 2023 | 7868000 | 9.41M | 119.64% |
|---|---|---|---|
| Sep 2023 | 5386000 | 5.58M | 103.64% |
| Dec 2023 | 3176000 | 5.05M | 159.01% |
| Mar 2024 | 1446000 | 8.43M | 583.61% |
| Mar 2023 | 0 | 0 | 0 |
|---|---|---|---|
| Jun 2023 | 1.78K | 0 | 0 |
| Sep 2023 | 0 | 0 | 0 |
| Dec 2023 | 0 | 0 | 0 |
NeuroSense Therapeutics Ltd. alternative data
| Aug 2023 | 3 |
|---|---|
| Sep 2023 | 3 |
| Oct 2023 | 3 |
| Nov 2023 | 3 |
| Dec 2023 | 3 |
| Jan 2024 | 14 |
| Feb 2024 | 14 |
| Mar 2024 | 14 |
| Apr 2024 | 14 |
| May 2024 | 18 |
| Jun 2024 | 18 |
| Jul 2024 | 18 |
NeuroSense Therapeutics Ltd. other data
-
What's the price of NeuroSense Therapeutics Ltd. stock today?
One share of NeuroSense Therapeutics Ltd. stock can currently be purchased for approximately $0.69.
-
When is NeuroSense Therapeutics Ltd.'s next earnings date?
Unfortunately, NeuroSense Therapeutics Ltd.'s (NRSNW) next earnings date is currently unknown.
-
Does NeuroSense Therapeutics Ltd. pay dividends?
No, NeuroSense Therapeutics Ltd. does not pay dividends.
-
How much money does NeuroSense Therapeutics Ltd. make?
NeuroSense Therapeutics Ltd. has a market capitalization of 45.45M.
-
What is NeuroSense Therapeutics Ltd.'s stock symbol?
NeuroSense Therapeutics Ltd. is traded on the NASDAQ under the ticker symbol "NRSNW".
-
What is NeuroSense Therapeutics Ltd.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of NeuroSense Therapeutics Ltd.?
Shares of NeuroSense Therapeutics Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does NeuroSense Therapeutics Ltd. have?
As Jul 2024, NeuroSense Therapeutics Ltd. employs 18 workers, which is 29% more then previous quarter.
-
What is NeuroSense Therapeutics Ltd.'s official website?
The official website for NeuroSense Therapeutics Ltd. is neurosense-tx.com.
-
How can i contact NeuroSense Therapeutics Ltd.?
NeuroSense Therapeutics Ltd. can be reached via phone at +972 9 953 1142.
NeuroSense Therapeutics Ltd. company profile:
NeuroSense Therapeutics Ltd.
neurosense-tx.comNASDAQ
18
Biotechnology
Healthcare
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for debilitating neurodegenerative diseases in Israel. Its lead product candidate is PrimeC, a novel oral formulation for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline product candidates include StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Herzliya, 4676670
CIK: 0001875091
ISIN: IL0011811630
CUSIP: M74240116
